Biocompatibility reflected by haemostasis variables during cardiopulmonary bypass using heparin-coated circuits

Thoracic and Cardiovascular Surgeon

Volumn 45, Issue 4, 1997, Pages 163-167

  Borowiec, J ^a,c   Bagge, L ^a   Saldeen, T ^b   Thelin, S ^a  

^a University Hospital   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Biocompatibility; Cardiopulmonary bypass; Heparin coating

Indexed keywords

HEPARIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTAMINE; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ACUTE PHASE RESPONSE; ARTICLE; BIOCOMPATIBILITY; BLOOD CELL; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CELL DAMAGE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; ENDOTHELIUM INJURY; HEMOSTASIS; HEPARINIZATION; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030767165     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1013716     Document Type: Article

References (30)

1. Arnander, C., M. Dryjski, R. Larsson, P. Olsson, and J. Swedenborg: Thrombin uptake and inhibition on endothelium and surface with a stable heparin coating. A comparative in vitro study. J. Biomed. Mater Res. 20 (1986) 235-246
2. Blann, A. D., J. Hopkins, J. Winkles, and A. C. Wainwright: Plasma and serum von Willebrand factor antigen concentrations in connective tissue disorders. Ann. Clin. Biochem. 29 (1992) 67-71
3. Borowiec, J., S. Thelin, L. Bagge, J. van der Linden, E. Thörnö, and H.-E. Hansson: Heparin-coated cardiopulmonary circuits and 25% reduction of heparin dose in coronary artery surgery - a clinical study. Upsala, J. Med. Sci. 97 (1992) 55-66
4. Borowiec, J., S. Thelin, L. Bagge, L. Nilsson, P. Venge, and H.-E. Hansson: Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study. J. Thorac. Cardiovasc. Surg. 104 (1992) 642-647
5. Brommer, E. J. P., and P. Brakman: Developments in fibrinolysis. In Poller, L. (ed.): Recent advances in blood coagulation, 5. Edinburgh-London-Melbourne-New York-Toyko, Churchill Livingstone, 1991 pp 17-34
6. Colman, R. W.: Platelet and neutrophil activation in cardiopulmonary bypass. Ann. Thorac. Surg. 49 (1990) 32-34
7. Fosse, E., O. Moen, E. Johnson, G. Semb, V. Brockmeier, T. E. Mollnes, M. Fagerhol, and P. Venge: Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann. Thorac. Surg. 58 (1994) 472-477
8. Hattori, R., K. K. Hamilton, R. P. McEver, and P.J. Sims: Complement C5b-9 stimulates von Willebrand factor secretion from human endothelium. Circulation 78 (1988) II 117
9. Holdright, D. R., B. J. Hunt, R. Parratt, H. Segal, D. Clarke, D. Taggart, C. Bennett, and P. Collins: The effects of cardiopulmonary bypass on systemic and coronary levels of von Willebrand factor. Eur. J. Cardio-Thorac. Surg. 9 (1995) 18-21
10. Holt, J. C., and S. Niewiarowski: Biochemistry of alpha granule proteins. Semin. Hematol. 22 (1985) 151-163
11. Jaffe, E. A., L. W. Hoyer, and R. L. Nachman: Synthesis of von Willebrand factor by cultured human endothelial cells. Proc. Natl. Acad. Sci. USA 71 (1974) 1906-1909
12. Jansen, N. J. G., W. van Oeveren, L. v. d. Brouk, H. M. Oudemans-van Straaten, C. P. Stoutenbeek, M. Chang Noek Joen, K. J. Roozendaal, L. Eysmann, and O. R. H. Wildevuur: Inhibition by dexamethason of the reperfusion phenomena in cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 102 (1991) 515-525
13. Kirklin, J. K., S. Westaby, E. H. Blackstone, J. W. Kirklin, D. E. Chenoweth, and A. D. Pacitico: Complement and the damaging effects of cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 86 (1983) 854-857
14. Knot, E. A. R., E. de Jong, J. W. ten Cate, L. K. Gie, and E. A. van Royen: Antithrombin III: biodistribution in healthy volunteers. Thromb. Haemostas 58 (1987) 1008-1011
15. Kodama, K., B. Pasche, P. Olsson, L. Adolfsson, O. Larm, and J. Riesenfeld: Antithrombin III binding to surface immobilized heparin and its relation to FXa inhibition. Thromb. Haemostas 58 (1987) 1064-1067
16. Larm, O., R. Larsson, and P. Olsson: A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified terminal residue. Biomet. Med. Dev. Art.Org. 11 (1983) 161-173
17. Laurell, C. B.: Quantitative estimation of proteins by electrophoresis and agarose gel containing antibodies. Ann. Biochem. 15 (1966) 45-52
18. Mancini, G., A. O. Carbonara, and J. K. Heremans: Immunochemical quantitation of antigens by single radial immunodiffusion. Int. J. Immunochem. 2 (1965) 253-254
19. Menasche, P., J. Peynet, N. Haeffner-Cavaillon, M. P. Carreno, T. De Chaumaray, V. Dillisse, B. Faris, A. Piwnica, C. Bloch, and A. Tedgui: Influence of temperature on neutrophil trafficking during clinical cardiopulmonary bypass. Circulation 92 (1995) II 334-340
20. Nilsson, L., K. E. Storm, S. Thelin, L. Bagge, J. Hultman, J. Thorelius, and U. Nilsson: Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig. Artif. Organs 14 (1989) 46-48
21. Paramo, J.A., J. Rifon, R. Lorens, J. Casares, M. J. Paloma, and E. Rocha: Intra- and postoperative fibrinolysis in patients undergoing cardiopulmonary bypass surgery. Haemostasis 21 (1991) 58-64
22. Plow, E.: Alternative pathways to fibrinolysis. J. Clin. Invest. 56 (1975) 30-38
23. Ray, M. J., N. A. Marsh, and C. A. Hawson: Relation of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass. Blood Coagul. Fibrinolysis 5 (1994) 679-685
24. Thelin, S., L. Bagge, J. Hultman, J. Borowiec, L. Nilsson, and J. Thorelius: Heparin-coated cardiopulmonary bypass circuits reduce blood cell trauma. Experiments in the pig. Eur. J. Cardio-Thorac. Surg. 5 (1991) 486-491
25. Tonz, M., T. Mihaljevic, L. K. von Segesser, J. Fehr, E. R. Schmid, and M. I. Turina: Acute lung injury during cardiopulmonary bypass. Are the neutrophils responsible? Chest 108 (1995) 1551-1556
26. Valen, G., E. Eriksson, B. Risberg, and J. Vaage: Fibrinolysis during cardiac surgery. Eur. J. Cardio-Thorac. Surg. 8 (1994) 324-330
27. Welch, M., J. T. Douglas, J. V. Smyth, and M. C. Walker: Systemic endotoxaemia and fibrinolysis during aortic surgery. Eur. J. Vasc. Endovasc. Surg. 9 (1995) 228-232
28. Videm, V., L. Nilsson, P. Venge, and J. L. Svennevig: Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass. Artif. Organs 15 (1991) 90-95
29. Videm, V., J. Svennevig, E. Fosse, G. Semb, A. Österud, T. Mollnes: Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. J. Thorac. Cardiovasc. Surg. 103 (1992) 806-813
30. Zilla, P., U. von Oppell, and M. Deutsch: The endothelium: A key to the future. J. Cardiac. Surg. 8 (1993) 32-60